Gynecologic Oncology | Specialty

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

Study Highlights Impact of Race, Geography on Genetic Variation in Endometrial Cancer

February 9th 2018

An analysis of black women of Caribbean descent with type I or type II endometrial cancer showed that this population expressed significant differences in genetic variations compared with a nationwide population of patients with endometrial cancer.

Dr. Taylor on the Future of Treatments for Endometrial Cancer

February 6th 2018

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the future of treatments for patients with endometrial cancer.

Vaccine Therapy Shows Promise in Cervical Cancer

February 1st 2018

Sharad Ghamande, MD, discusses the findings from GOG/NRG-0265, as well as the impact of vaccines for patients with cervical cancer.

Dr. Coleman on the Role of Ramucirumab in Gynecologic Cancer

January 30th 2018

Robert Coleman, MD, professor in the department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses the role of ramucirumab (Cyramza) in patients with gynecologic cancer.

Obesity Impedes Detection of Cervical Precancer, Increasing Cancer Risk

January 24th 2018

Women with a body mass ≥30 kg/m2 had a greater 5-year risk for cervical cancer than lighter women, possibly due to underdiagnosis of cervical precancer.

Dr. Haldorsen on the Contributions of Imaging in Endometrial Cancer

January 24th 2018

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the contributions of imaging in endometrial cancer.

Dr. Mahantshetty on Challenges With Concomitant Chemoradiation Trial in Cervical Cancer

January 23rd 2018

Umesh Mahantshetty, MD, MBBS, radiation oncologist, Tata Memorial Hospital, Mumbai, discusses challenges with a trial (NCT00193791) conducted by Tata Memorial Hospital seeking to solidify the impact of concomitant chemoradiation with FIGO stage IIIb squamous cervical cancer.

Dr. Taylor Discusses the Management of Endometrial Cancer

January 18th 2018

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the management of endometrial cancer.

Dr. Hensley on dMRR and MSI-H Testing in Endometrial Cancer

January 17th 2018

Martee L. Hensley, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses DNA mismatch repair deficiency (dMMR) and microsatellite-instability high (MSI-H) testing for patients with endometrial cancer.

Preoperative Imaging Remains Integral to Endometrial Cancer Diagnosis

January 15th 2018

Ingfrid Haldorsen, MD, discusses the role of imaging in the diagnosis of patients with endometrial cancer.

Global HPV Vaccination Reshaping Standard of Care for Cervical Cancer Prevention

January 15th 2018

Xavier Bosch, MD, discusses a second-generation vaccination against HPV for the prevention of cervical cancer.

Dr. Ghamande on the AIM2CERV Trial in Cervical Cancer

January 13th 2018

Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.

Dr. Haldorsen on the Importance of Imaging in the Diagnosis of Endometrial Cancer

January 11th 2018

Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the importance of imaging in the diagnosis of endometrial cancer.

Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer

January 11th 2018

Martee L. Hensley, MD, discusses the role of MSI-H and dMMR testing in the management of endometrial cancer.

Dr. Taylor on Treatments in Development for Endometrial Cancer

January 4th 2018

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses treatments in development for patients with endometrial cancer.

Dr. Mahantsetty on Unmet Needs in Cervical Cancer

December 29th 2017

Umesh Mahantshetty, MD, MBBS, radiation oncologist, Tata Memorial Hospital, Mumbai, India, discusses unmet needs for patients with cervical cancer.

Dr. Hensley on Lynch Syndrome in Endometrial Cancer

December 28th 2017

Martee L. Hensley, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses Lynch syndrome for patients with endometrial cancer.

Dr. Ledermann on Systemic Treatment for Rare Gynecologic Tumors

December 27th 2017

Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, United Kingdom, discusses systemic treatment for patients with rare gynecologic tumors.

Dr. Taylor on the Current Treatment Landscape for Endometrial Cancer

December 21st 2017

Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the current treatment landscape of advanced endometrial cancer.

Cotesting Unlikely to Detect More Cervical Cancers Than HPV Testing Alone

December 20th 2017

Use of both a Pap smear and an HPV test did not identify more cervical cancers than HPV testing alone.